News

Amkor Technology Announces Leadership Change with Susan Kim

Amkor Technology Announces Leadership Change with Susan Kim

Amkor Technology Welcomes New Leadership

Amkor Technology, Inc. (NASDAQ: AMKR), a prominent company in the semiconductor packaging and testing sector, is gearing up for a major leadership shift. Recently, the company announced that Susan Y. Kim will succeed James Kim as the Chairman of the Board, following his retirement. This transition marks a pivotal moment for Amkor, with the exact date of the change yet to be determined.

Celebrating a Legacy of Leadership

James Kim, who founded Amkor back in 1968, has made a lasting impact on the semiconductor industry. His decades-long commitment has significantly shaped the realm of outsourced semiconductor assembly and testing. In recognition of his invaluable contributions, Amkor plans to honor him with the title of Chairman Emeritus, allowing his legacy to continue influencing the company.

Strategic Growth Amidst Transition

The timing of this leadership change aligns with Amkor's position on the cusp of new opportunities, bolstered by its advanced packaging capabilities and extensive global reach. Giel Rutten, the President and CEO of Amkor, has expressed sincere appreciation for James Kim's influential leadership while warmly welcoming Susan Kim, hoping for supportive family ties as they move forward together.

Amkor's Industry Position

As the largest U.S.-based OSAT (Outsourced Semiconductor Assembly and Test) provider, Amkor Technology plays a vital role as a manufacturing partner for top semiconductor firms, foundries, and electronics OEMs. The company supports a wide array of industries, driving innovation in areas such as communications, automotive, computing, and consumer electronics.

Commitment to Innovation

This leadership transition underscores Amkor's dedication to staying competitive in advanced packaging technologies. With a strong reputation for innovation and quality, the future appears bright under Susan Y. Kim's leadership as Amkor works to maintain its momentum in the industry.

Recent Financial Performance

Amkor Technology recently unveiled strong financial results for the second quarter, reporting revenues of $1.46 billion and earnings per share of $0.27. This marks a notable 7% growth compared to the previous quarter, largely driven by increased demand for advanced packaging solutions in premium smartphones and AI technologies. However, Amkor's third-quarter forecast was met with mixed reactions as it slightly missed analysts' expectations, mainly due to delays in advancing its 2.5D technology and a slower recovery in the automotive and industrial sectors.

Market Analysts Weigh In

In response to these developments, analysts from Needham have increased their price target for Amkor Technology from $40 to $45, while keeping a 'Buy' rating. Despite some challenges, Amkor remains optimistic about its full-year revenue projections for 2.5D technology, anticipating that revenues will quadruple compared to last year. Plans to boost production capacity for 2.5D technology are also scheduled for 2025.

Looking Towards the Future

As the demand for high-end electronics—like smartphones, laptops, and wearables—grows in the latter part of the year, Amkor forecasts revenue of around $1.835 billion for the upcoming quarter. Even though the projections for the automotive and industrial markets appear flat, there’s considerable expected demand in high-performance computing and ARM-based PCs.

Investing Insights

With its leadership transition underway, Amkor Technology, Inc. remains focused on its economic stability and strategic positioning in the market, which is crucial for stakeholders. The company's strong market capitalization reflects its solid footing in the semiconductor industry. Analysts, while cautiously optimistic, note that Amkor continues to show a strong performance trajectory.

Frequently Asked Questions

Who is the new Chairman of Amkor Technology?

Susan Y. Kim has been appointed as the new Chairman of Amkor Technology, succeeding James Kim upon his retirement.

What was James Kim's contribution to Amkor Technology?

James Kim founded Amkor Technology in 1968 and played a pivotal role in developing the semiconductor assembly and test services industry over his extensive career.

What are Amkor's recent financial highlights?

Recently, Amkor reported revenues of $1.46 billion for the second quarter, with earnings per share at $0.27, marking a 7% sequential growth.

How does Amkor Technology plan to address its future?

Under the leadership of Susan Y. Kim, Amkor aims to continue its commitment to innovation and advanced packaging technologies to drive growth.

What market response has Amkor received from analysts?

Analysts from Needham have raised Amkor's price target from $40 to $45 while maintaining a 'Buy' rating, despite some challenges in the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading